Eptifibatide acetate (C09-0878-271)

Introduction:Eptifibatide acetate is a cyclic heptapeptide. It is the member of the class arginin-glycin-aspartat-mimetics. Eptifibatide has a short half-life. The drug decreases the risk of myocardial infarction (MI). Eptifibatide acetate might be associated with thrombocytopenia.Eptifibatide acetate is a selective inhibitor of Integrin alpha IIb ( platelet glycoprotein IIb) /Integrin beta 3 (platelet glycoprotein IIIa) receptors. Specification: ≥98% Molecular Formula: C35H49N11O9S2·xC2H4O2 Molecular Weight: 831.96 (free base basis) PubChem CID: 12001375 Isomeric SMILES: CC(=O)O.C1C[C@H]2C(=O)N[C@@H](CSSCCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N Beilstein Registry Number: 9608167 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/E339599-SCI_5996ec75c3a07831d74bf5a956e5a86c.pdf